US$ 23.07
glp-1 receptor agonist diarrhea management Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine can a glp 1 cause
Description
Similar content being viewed by others Introduction The prevalence of people living with type 2 diabetes (T2D) has increased to over 450 million worldwide and is expected to increase further in the next decades [1]
J., Cartwright, B

Less frequent dosing may outweigh the discomfort of a little jab
Efficacy and safety of once-weekly efpeglenatide monotherapy versus placebo in type 2 diabetes: the AMPLITUDE-M randomized controlled trial
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes
